Evidence map›Paper›PMID 42607098›Full record

ArticlePloS one2026

Study protocol for first national vasa previa perinatal registry.

Kayla E Paulosky, Antonio Santos-Roca, Chiara Corbetta-Rastelli, Efe Cudjoe, David Esterquest, Oluwaseun Fadairo, Brittany A Fickau, Brenna Funfar, Allison Perelman, Naima Ross and 21 more

Abstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Kayla E PauloskyDepartment of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United states of America.
Antonio Santos-RocaDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York, United states of America.
Chiara Corbetta-RastelliDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, California, United states of America.
Efe CudjoeDepartment of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United states of America.
David EsterquestDepartment of Obstetrics and Gynecology, Advocate Lutheran General Hospital, Park Ridge, Illinois, United states of America.ORCID https://orcid.org/0009-0006-2158-5556
Oluwaseun FadairoDepartment of Obstetrics and Gynecology, Albany Medical Center, Albany, New York, United states of America.
Brittany A FickauDepartment of Obstetrics and Gynecology, Cleveland Clinic Akron General, Akron, Ohio, United states of America.ORCID https://orcid.org/0000-0003-1616-6761
Brenna FunfarDepartment of Obstetrics and Gynecology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United states of America.
Allison PerelmanDepartment of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, United states of America.ORCID https://orcid.org/0009-0008-0669-0272
Naima RossDepartment of Obstetrics and Gynecology, NYU Grossman School of Medicine, New York, New York, United states of America.
Carrie A SibbaldDepartment of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United states of America.
Logan TodhunterDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York, United states of America.
Bethany T WaitesDepartment of Obstetrics and Gynecology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United states of America.
Andrew H ChonDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United states of America.ORCID https://orcid.org/0000-0002-6624-1662
Chelsea A DeBoltDepartment of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, United states of America.ORCID https://orcid.org/0000-0002-9532-4109
Kathryn DrennenDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York, United states of America.
Laura HanksDepartment of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United states of America.ORCID https://orcid.org/0009-0002-1943-3837
Angie C JelinDepartment of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United states of America.
Michelle KushDepartment of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United states of America.ORCID https://orcid.org/0009-0002-4784-4166
Tara LynchDepartment of Obstetrics and Gynecology, Albany Medical Center, Albany, New York, United states of America.
Amol MalsheDepartment of Obstetrics and Gynecology, Cleveland Clinic Akron General, Akron, Ohio, United states of America.
Lauren A MillerDepartment of Obstetrics and Gynecology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United states of America.
Jessian L MunozDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, United states of America.ORCID https://orcid.org/0000-0003-0431-5280
Mary E NortonDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, California, United states of America.
Monica RinconDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United states of America.ORCID https://orcid.org/0000-0001-5574-585X
Ashley S RomanDepartment of Obstetrics and Gynecology, NYU Grossman School of Medicine, New York, New York, United states of America.
Melissa RussoDepartment of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United states of America.
Rachelle St OngeDepartment of Obstetrics and Gynecology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United states of America.ORCID https://orcid.org/0009-0001-5297-1373
Yinka OyeleseDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United states of America.
Guy SteinbergDepartment of Obstetrics and Gynecology, Advocate Medical Group/Advocate Health, Downers Grove, Illinois, United states of America.
Marika ToscanoDepartment of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United states of America.ORCID https://orcid.org/0000-0002-7746-2866

Funding

The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)K12AR084229 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Daniel Ernest Ford, NANCY E GLASS · 2023 to 2026
$2.7M
Johns Hopkins Women's Reproductive Health Research Career Development ProgramK12HD103036 · NICHD · JOHNS HOPKINS UNIVERSITY · PI SATIN, ANDREW J. · 2020 to 2024
$1.5M
NIAMS NIH HHS K12 AR084229NICHD NIH HHS K12 HD103036
6 · The paper itself

Abstract

Vasa previa is a rare but potentially catastrophic obstetric condition characterized by unprotected fetal blood vessels over or adjacent to the internal cervical os. Although advances in prenatal ultrasound have dramatically improved neonatal survival through planned cesarean delivery, many aspects of vasa previa remain poorly understood. Existing studies are limited by small sample sizes, single-center designs, heterogeneous diagnostic criteria, and inconsistent reporting of clinical outcomes, highlighting the need for large, systematically collected multicenter datasets. Here we describe, to our knowledge, the first United States multicenter registry of pregnancies complicated by vasa previa without concurrent placenta previa, the U.S. Vasa Previa Registry (US-VPR). This report outlines the rationale, design, and implementation of a large, multicenter, retrospective registry developed to characterize patient demographics, risk factors, placental pathology, natural history, antenatal management, maternal outcomes, neonatal outcomes, and healthcare utilization associated with vasa previa. The US-VPR includes contributions from 15 tertiary referral centers and represents the largest multicenter cohort of pregnancies complicated by vasa previa without concurrent placenta previa reported to date. By leveraging multicenter collaboration and standardized data collection, the registry provides a unique opportunity to characterize variation in clinical practice and outcomes across referral centers, strengthen the evidence base for this rare condition, and inform future prospective studies and evidence-based patient counseling.

Indexed as

RegistriesVasa PreviaFemaleHumansMulticenter Studies as TopicObservational Studies as TopicPregnancyPregnancy OutcomeRetrospective StudiesRisk FactorsUnited States

Identifiers

PMID42607098
PMCPMC13480644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.